Myelofibrosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
{{CMG}}{{AE}}{{MJK}} | {{CMG}}{{AE}}{{MJK}} | ||
{{SK}} Agnogenic myeloid metaplasia; Assmann's Disease; | {{SK}} Agnogenic myeloid metaplasia; Assmann's Disease; Chronic idiopathic myelofibrosis; Heuck-Assmann disease; Idiopathic myelofibrosis; Primary myelofibrosis; Secondary myelofibrosis; Myelosclerosis | ||
==[[Myelofibrosis overview|Overview]]== | ==[[Myelofibrosis overview|Overview]]== |
Revision as of 18:42, 7 March 2016
For patient information, click here
Template:DiseaseDisorder infobox
Myelofibrosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Myelofibrosis On the Web |
American Roentgen Ray Society Images of Myelofibrosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Synonyms and keywords: Agnogenic myeloid metaplasia; Assmann's Disease; Chronic idiopathic myelofibrosis; Heuck-Assmann disease; Idiopathic myelofibrosis; Primary myelofibrosis; Secondary myelofibrosis; Myelosclerosis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myelofibrosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies